Endogenous nitric oxide formation correlates negatively with circulating matrix metalloproteinase (MMP)-2 and MMP-9 levels in black subjects
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Endogenous nitric oxide formation correlates negatively with circulating matrix metalloproteinase (MMP)-2 and MMP-9 levels in black subjects
Authors
Keywords
-
Journal
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume 360, Issue 1-2, Pages 393-399
Publisher
Springer Nature
Online
2011-09-28
DOI
10.1007/s11010-011-1079-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Consistent Alterations of Circulating Matrix Metalloproteinases Levels in Untreated Hypertensives and in Spontaneously Hypertensive Rats: A Relevant Pharmacological Target
- (2011) Vanessa Fontana et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Sodium nitrite downregulates vascular NADPH oxidase and exerts antihypertensive effects in hypertension
- (2011) Marcelo F. Montenegro et al. FREE RADICAL BIOLOGY AND MEDICINE
- Matrix metalloproteinase 9 gene haplotypes affect left ventricular hypertrophy in hypertensive patients
- (2010) Riccardo Lacchini et al. CLINICA CHIMICA ACTA
- Interethnic Differences in the Distribution of Matrix Metalloproteinases Genetic Polymorphisms Are Consistent with Interethnic Differences in Disease Prevalence
- (2010) Riccardo Lacchini et al. DNA AND CELL BIOLOGY
- Matrix Metalloproteinase Inhibition Improves Cardiac Dysfunction and Remodeling in 2-Kidney, 1-Clip Hypertension
- (2010) Élen Rizzi et al. JOURNAL OF CARDIAC FAILURE
- Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome
- (2009) Flavia M. Gonçalves et al. CLINICA CHIMICA ACTA
- Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents
- (2009) Vanessa A. Belo et al. CLINICAL BIOCHEMISTRY
- Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling
- (2009) Michele M. Castro et al. MATRIX BIOLOGY
- Racial Differences in Incident Heart Failure among Young Adults
- (2009) Kirsten Bibbins-Domingo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nitrite or sildenafil, but not BAY 41-2272, blunt acute pulmonary embolism-induced increases in circulating matrix metalloproteinase-9 and oxidative stress
- (2009) Carlos A. Dias-Junior et al. THROMBOSIS RESEARCH
- Differences in the Incidence of Congestive Heart Failure by Ethnicity
- (2008) Hossein Bahrami et al. ARCHIVES OF INTERNAL MEDICINE
- Inverse relationship between markers of nitric oxide formation and plasma matrix metalloproteinase-9 levels in healthy volunteers
- (2008) Caroline Demacq et al. CLINICA CHIMICA ACTA
- Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects
- (2008) Caroline Demacq et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats
- (2008) Marcio L.L. Martinez et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Serial measurements of whole blood nitrite in an intensive care setting
- (2008) Eva S. Kehmeier et al. FREE RADICAL BIOLOGY AND MEDICINE
- Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats
- (2007) Michele M. Castro et al. ATHEROSCLEROSIS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started